Intellectus Partners’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$698K	Buy	54,475 +3,350	+7%	+$42.7K	0.14%	167
2025 Q4	$460K	Sell	51,125 -35,850	-41%	-$494K	0.09%	201
2025 Q3	$1.5M	Buy	86,975 +1,000	+1%	+$12.3K	0.29%	92
2025 Q2	$806K	Buy	85,975 +3,150	+4%	+$25.9K	0.17%	147
2025 Q1	$589K	Buy	82,825 +8,300	+11%	+$83.8K	0.15%	171
2024 Q4	$869K	Buy	74,525 +15,700	+27%	+$245K	0.19%	143
2024 Q3	$1.21M	Buy	58,825 +600	+1%	+$13.8K	0.31%	97
2024 Q2	$1.3M	Buy	58,225 +1,225	+2%	+$29.2K	0.36%	77
2024 Q1	$1.57M	Buy	57,000 +1,350	+2%	+$37.5K	0.41%	70
2023 Q4	$1.7M	Buy	55,650 +4,900	+10%	+$141K	0.49%	59
2023 Q3	$1.6M	Sell	50,750 -650	-1%	-$25.2K	0.51%	53
2023 Q2	$2.1M	Buy	51,400 +5,135	+11%	+$208K	0.63%	40
2023 Q1	$1.72M	Buy	46,265 +600	+1%	+$23.5K	0.54%	51
2022 Q4	$1.59M	Buy	45,665 +3,700	+9%	+$176K	0.56%	53
2022 Q3	$2.35M	Sell	41,965 -1,260	-3%	-$78.2K	0.84%	29
2022 Q2	$2.24M	Sell	43,225 -1,225	-3%	-$62.2K	0.77%	29
2022 Q1	$3.23M	Sell	44,450 -3,075	-6%	-$261K	0.96%	19
2021 Q4	$5.62M	Sell	47,525 -3,425	-7%	-$429K	1.43%	11
2021 Q3	$6.83M	Buy	50,950 +2,300	+5%	+$348K	1.66%	9
2021 Q2	$7.88M	Sell	48,650 -22,975	-32%	-$1.79M	1.78%	8
2021 Q1	$4.61M	Buy	71,625 +5,700	+9%	+$383K	1.27%	13
2020 Q4	$3.59M	Buy	65,925 +20,275	+44%	+$736K	1.07%	18
2020 Q3	$908K	Buy	+45,650	New	+$952K	0.34%	88